Prise en charge des cancers du rectum localement avancés : quel rôle pour le pathologiste en 2011 ?

Frykholm, 2001, Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, non-resectable adenocarcinoma of the rectum, Int J Radiat Oncol Biol Phys, 50, 427, 10.1016/S0360-3016(01)01479-1 Bosset, 2006, Chemotherapy with preoperative radiotherapy in rectal cancer, N Engl J Med, 355, 1114, 10.1056/NEJMoa060829 Gérard, 2006, Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancers: results of FFCD 9203, J Clin Oncol, 24, 4620, 10.1200/JCO.2006.06.7629 Braendengen, 2008, Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in non-resectable rectal cancer, J Clin Oncol, 26, 3687, 10.1200/JCO.2007.15.3858 Visser, 2007, The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam, J Surg Oncol, 95, 447, 10.1002/jso.20713 Quirke, 1986, Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision, Lancet, 2, 996, 10.1016/S0140-6736(86)92612-7 Nagtegaal, 2002, Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control, J Clin Oncol, 20, 1729, 10.1200/JCO.2002.07.010 Maslekar, 2007, Mesorectal grades predict recurrences after curative resection for rectal cancer, Dis Colon Rectum, 50, 168, 10.1007/s10350-006-0756-2 Wibe, 2002, Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer, Br J Surg, 89, 327, 10.1046/j.0007-1323.2001.02024.x Birbeck, 2002, Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery, Ann Surg, 235, 449, 10.1097/00000658-200204000-00001 Das, 2006, Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer, Am J Clin Oncol, 29, 219, 10.1097/01.coc.0000214930.78200.4a Yoon, 2010, Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer, Tumori, 96, 568, 10.1177/030089161009600409 Bouzourene, 2003, Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy, Hum Pathol, 34, 541, 10.1016/S0046-8177(03)00176-X Shia, 2004, Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome, Am J Surg Pathol, 28, 215, 10.1097/00000478-200402000-00009 Rödel, 2005, Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer, J Clin Oncol, 23, 8688, 10.1200/JCO.2005.02.1329 Nagtegaal, 2002, The role of pathologists in the quality control of diagnosis and treatment of rectal cancer – an overview, Eur J Cancer, 38, 964, 10.1016/S0959-8049(02)00056-4 Quirke, 2007, Reporting colorectal cancer, Histopathology, 50, 103, 10.1111/j.1365-2559.2006.02543.x Parfitt, 2007, The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment, J Clin Pathol, 60, 849, 10.1136/jcp.2006.043802 De Hertogh, 2010, Practical and molecular evaluation of colorectal cancer: new roles for the pathologist in the era of targeted therapy, Arch Pathol Lab Med, 134, 853, 10.5858/134.6.853 Quirke, 1988, The prediction of local recurrence in rectal adenocarcinoma by histopathological examination, Int J Colorectal Dis, 3, 127, 10.1007/BF01645318 Bateman, 2009, Rectal cancer staging post-neoadjuvant therapy: how should the changes be assessed?, Histopathology, 54, 713, 10.1111/j.1365-2559.2009.03292.x Guillem, 2007, A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation, Ann Surg, 245, 88, 10.1097/01.sla.0000232540.82364.43 Rullier, 2008, Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival, Am J Surg Pathol, 32, 45, 10.1097/PAS.0b013e3180dc92ab Colombo, 2011, Clinical impact of lymph node status in rectal cancer, Surg Oncol, 20, e227, 10.1016/j.suronc.2011.08.004 Shia, 2011, Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy, Am J Surg Pathol, 35, 127, 10.1097/PAS.0b013e318200cf78 Bibeau F, Frugier H, Palasse J, Leaha C, Gunin de Vallerin A, Château M-C, et al. Impact des traitements néoadjuvants des adénocarcinomes rectaux localement évolués sur la régression tumorale histologique de la tumeur primitive et des ganglions lymphatiques. Étude prospective sur une série de 254 cas. Journées francophones d’hépatogastroentérologie et d’oncologie digestive 2011, Paris 24–27 mars. Quah, 2008, Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation, Cancer, 113, 57, 10.1002/cncr.23516 Peschaud, 2008, The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer, Ann Surg, 248, 1067, 10.1097/SLA.0b013e31818842ec Lindebjerg, 2009, The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy, Colorectal Dis, 11, 264, 10.1111/j.1463-1318.2008.01599.x Maggiori, 2010, Qu’attend le chirurgien de l’imagerie dans le bilan préopératoire d’un cancer du rectum ?, Hépato-Gastro, 17, 383 Dworak, 1997, Pathological features of rectal cancer after preoperative radiochemotherapy, Int J Colorectal Dis, 12, 19, 10.1007/s003840050072 Gosens, 2007, Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma, Clin Cancer Res, 13, 6617, 10.1158/1078-0432.CCR-07-1197 Rullier, 2010, Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma, Am J Surg Pathol, 34, 562, 10.1097/PAS.0b013e3181d438b0 Ryan, 2005, Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer, Histopathology, 47, 141, 10.1111/j.1365-2559.2005.02176.x Washington, 2009, Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, Arch Pathol Lab Med, 133, 1539, 10.5858/133.10.1539 Rullier, 2005, Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma, Am J Surg Pathol, 29, 602, 10.1097/01.pas.0000153120.80385.29 Sataloff, 1995, Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome, J Am Coll Surg, 180, 297 Shia, 2002, Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy, Am J Surg Pathol, 26, 863, 10.1097/00000478-200207000-00004 Maas, 2010, Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data, Lancet Oncol, 11, 835, 10.1016/S1470-2045(10)70172-8 Aschele, 2011, Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the Star-01 randomized phase III trial, J Clin Oncol, 29, 2773, 10.1200/JCO.2010.34.4911 Rouanet, 2011, Réponse tumorale complète des cancers du rectum après traitement néoadjuvant : faut-il opérer ? Point de vue du chirurgien, Bull Cancer, 98, 25, 10.1684/bdc.2010.1292 Bretagnol, 2011, Chirurgie transanale : pour qui et comment ?, Hépato-Gastro, 18, 133 Habr-Gama, 2009, The strategy “wait and watch” in patients with a cancer of bottom stocking rectum with a complete clinical answer after neoadjuvant radiochemotherapy, J Chir (Paris), 146, 237, 10.1016/j.jchir.2009.07.002 Habr-Gama, 2010, Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization, Colon Rectum, 53, 1692, 10.1007/DCR.0b013e3181f42b89 Habr-Gama, 2011, The need for effective radiosentitizing agents: experience in patients with complete pathological response, Anticancer Drugs, 22, 308, 10.1097/CAD.0b013e3283428193 Habr-Gama, 2009, Non-operative management of rectal cancer after neoadjuvant chemoradiation, Br J Surg, 96, 125, 10.1002/bjs.6470 Kuremsky, 2009, Biomarkers for response to neoadjuvant chemoradiation for rectal cancer, Int J Radiat Oncol Biol Phys, 74, 673, 10.1016/j.ijrobp.2009.03.003 Smith, 2006, Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy, Eur J Surg Oncol, 32, 55, 10.1016/j.ejso.2005.09.010 Jakob, 2004, Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neoadjuvant chemoradiotherapy in rectal cancer, J Pathol, 204, 562, 10.1002/path.1663 Jakob, 2005, Am J Surg Pathol, 29, 1304, 10.1097/01.pas.0000170346.55304.88 Guedj, 2011, Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas, Hum Pathol, 42, 1702, 10.1016/j.humpath.2011.01.015 Ho-Pun-Cheung, 2007, Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer, Int J Radiat Oncol Biol Phys, 68, 1094, 10.1016/j.ijrobp.2007.01.022 Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, et al. A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer. Pharmacogenomics J doi:10.1038/tpj.2010.62. Ghadimi, 2005, Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy, J Clin Oncol, 23, 1826, 10.1200/JCO.2005.00.406 Rimkus, 2008, Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer, Clin Gastroenterol Hepatol, 6, 53, 10.1016/j.cgh.2007.10.022 Azria, 2005, Prognostic impact of epidermal growth factor receptor (EGFR) expression on locoregional recurrence after preoperative radiotherapy in rectal cancer, BMC Cancer, 5, 62, 10.1186/1471-2407-5-62 Wheeler, 2004, Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade, Dis Colon Rectum, 47, 2025, 10.1007/s10350-004-0713-x Mandard, 1994, Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations, Cancer, 73, 2680, 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C Williams GT, Quirke P, Shepherd NA. Dataset for colorectal cancer, 2nd edition. London: The Royal College of Pathologists. Available at http://www.rcpath.org/resources/pdf/G049ColorectalDataset-Sep07.pdf.